Time filter

Source Type

Can, Turkey

Gawad Y.,CardioGenics
Medical Device and Diagnostic Industry | Year: 2010

Medical device products include disposable medical supplies, wound-management supplies, and diagnostic products. Immunoassays are chemical tests used to detect or quantify a specific substance, the analyte, in a blood or body fluid sample, using an immunological reaction. Proteins are released in blood when the heart is damaged. One vital application for cardiac markers is the point-of-care (POC) test market, encompassing those diagnostic tests that can be conducted at or near the site of patient care. A prime motivation for the development of new POC technology is the desire to reduce the time required to diagnose cardiac events such as heart attacks. When it comes to cardiac events and survival, the key factors for a successful recovery include the time required for diagnosis, the accuracy of that diagnosis, and appropriate clinical management. Source

CardioGenics | Entity website

Brief Company History CardioGenics was founded in Toronto, Ontario in 1997 as a biotechnology company dedicated to the development of products for the In-Vitro-Diagnostics market to meet unfulfilled needs. At the heart of CardioGenics Platform is a core technology for improving testing sensitivity to POC products ...

CardioGenics | Entity website

Stock Info Information for stock quote is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be delayed

CardioGenics | Entity website

November 4, 2015 | Mississauga CardioGenics Enters Into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap MISSISSAUGA, Ontario - November 4, 2015 -CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD") testing market, announced today that it, and its newly created Canadian subsidiary, have entered into a definitive asset purchase agreement to acquire substantially all of the assets of Plasticap ...

Discover hidden collaborations